Home » About Us » News » Press Releases
Press Releases
Corporate News
6/16/2008
MLS Completes Vybion Product Acquisition
5/13/2008
Meridian Signs Agreement to acquire Vybion Proteins
10/12/2007
USDA/APHIS EC 1774:2002 Approval For It’s Viral Antigens Production Facility
8/28/2007
Commencement Of Phase I/II Clinical Trials Of Parvovirus B19 Vaccine
8/7/2007
Awarded NIH Contract For Production Of Experimental Vaccines
5/4/2007
COMMERCIAL AVAILABILITY OF A NOVEL RESPIRATORY SYNCYTIAL VIRUS CLINICAL CHALLENGE STOCK
3/20/2007
Meridian Bioscience Completes Restructuring and Expansion of Meridian Life Science Business
1/4/2007
Meridian Bioscience Completes Production of Clinical Respiratory Syncytial Virus
12/10/2003
VAI to Manufacture Parvovirus Vaccine for NIH - Overview Press Release
Product News
4/4/2008
Escherichia coli
3/13/2008
Hepatitis C
2/25/2008
MAb Production Brochure
2/6/2008
Bone/Calcium Metabolism
1/29/2008
Infectious Disease Focus (TB/HIV)
1/15/2008
Autoimmune Diseases
12/31/2007
Lipoproteins
10/23/2007
Expanding Infectious Disease Product Line
9/18/2007
Apoptosis & Cancer Products
8/16/2007
Drugs of Abuse Pairing Table
7/16/2007
ISO 9001:2000 Certification
6/19/2007
Cardiac Regulator Protein Improves Survival after Heart Attack
5/8/2007
USDA/APHIS EC 1774/2002 Approval for Monoclonal Antibody Production Facility
4/20/2007
Influenza Antibodies and Antigens, including H5N1
4/15/2007
Laminin-5 and Cancer Invasion Research
12/1/2006
Diabetes Awareness Month
11/22/2006
Influenza Antibodies and Antigens
11/6/2006
Featured Products
10/24/2006
Increasing Demand for Rapid Detection of Cystatin C
9/14/2006
Human Papilloma Virus (HPV) Antibodies
8/30/2006
Antibodies Produced in Chickens
6/20/2006
Facility Expansion Completed for Monoclonal Antibody Production
12/15/2005
8/15/2005
BIODESIGN offers Mouse IgG as Analyte Specific Reagent (ASR) for use in Diagnostic Assay Development
7/22/2005
Price Optimization: Antibodies to Cancer Antigens
